查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1876482

全球临床试验诊断影像市场：产业分析、规模、份额、成长、趋势和预测（2025-2032 年）

Clinical Trial Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research近期发布了一份关于全球临床试验影像诊断市场的综合报告。该报告深入分析了市场结构，并对关键市场趋势进行了全面评估，包括驱动因素、发展趋势、机会和挑战。该研究报告提供了独家数据和统计信息，展现了2025年至2032年全球临床试验影像诊断市场的预期成长轨迹。

主要发现：

  • 临床试验诊断影像市场规模（2025年）：15亿美元
  • 预计市场价值（2032年）：25亿美元
  • 全球市场成长率（2025年至2032年复合年增长率）：7.5%

临床试验诊断影像市场 - 范围：

临床试验影像是指在临床试验中使用医学影像技术，例如磁振造影（MRI）、电脑断层扫描）、正子断层扫描（PET）和超音波检查，来评估新药、治疗方法和医疗设备的疗效和安全性。这些影像技术有助于研究人员准确诊断疾病、监测治疗进展并识别生物标记。随着製药和生物技术公司越来越依赖影像学证据来获得监管部门的核准并加速药物研发，对临床试验影像的需求也不断增长。

市场成长驱动因素：

全球临床试验影像市场受多种关键因素驱动，其中包括临床研究中先进影像技术的日益普及。癌症、心血管疾病和神经系统疾病等慢性疾病的盛行率不断上升，推动了药物试验中对基于影像的生物标记的需求。此外，全球临床试验数量的增加，以及对影像终点指标的严格监管要求，也促进了市场成长。人工智慧 (AI) 和机器学习 (ML) 与影像技术的整合进步，进一步提高了影像分析的准确性，有助于改善临床试验结果。

市场限制：

儘管临床试验影像市场拥有巨大的成长潜力，但也面临许多挑战，例如影像设备和基础设施高成本。复杂的区域监管合规要求也阻碍了市场扩张。此外，缺乏能够解读和分析影像资料的专业人员也影响了临床试验的高效发展。研究核准的延迟以及不同研究中心影像通讯协定的差异进一步增加了该市场的营运复杂性。

市场机会：

临床试验影像市场蕴藏着巨大的成长机会，主要得益于云端基础影像解决方案和远端监测技术的日益普及。人工智慧影像软体的开发有望提升即时数据处理能力并实现影像分析自动化，从而减少人为错误。此外，製药公司、委外研发机构(CRO) 和影像服务供应商之间的策略联盟有望简化临床试验影像工作流程。新兴市场（尤其是亚太地区）临床试验的扩张，为市场参与者带来了盈利的成长前景。

本报告解答的关键问题：

  • 推动全球临床试验影像市场成长的关键因素有哪些？
  • 人工智慧和机器学习的融合将如何提升临床试验中的诊断成像能力？
  • 哪些治疗领域在临床试验中主导采用诊断影像解决方案？
  • 临床试验影像市场的主要参与者有哪些？他们正在采取哪些策略来获得竞争优势？
  • 全球临床试验诊断影像市场有哪些新兴趋势和未来成长前景？

目录

第一章执行摘要

第二章 市场概览

  • 市场范围和定义
  • 市场动态
    • 司机
    • 抑制因素
    • 机会
    • 任务
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长展望
  • 新冠疫情影响分析
  • 预测因子－相关性和影响

第三章 加值见解

  • 产品和服务采用分析
  • 监管状态
  • 价值链分析
  • 重大交易和合併
  • PESTLE分析
  • 波特五力分析

第四章 价格趋势分析，2019-2032年

  • 主要亮点
  • 影响产品和服务价格的关键因素
  • 产品/服务价格分析
  • 区域价格和产品/服务偏好

第五章：全球临床试验诊断影像市场展望：

  • 主要亮点
    • 市场规模预测
    • 市场规模和年成长率
    • 绝对商机
  • 市场规模分析与预测
    • 2019-2024年历史市场规模分析
    • 目前市场规模分析及预测（2025-2032年）
  • 全球临床试验诊断影像市场展望：产品与服务
    • 引言/主要发现
    • 按产品和服务分類的历史市场规模和销售分析（2019-2024 年）
    • 按产品和服务分類的当前市场规模和销售分析及预测（2025-2032 年）
      • 服务
      • 软体
  • 市场吸引力分析：产品与服务
  • 全球临床试验诊断影像市场展望：模式
    • 引言/主要发现
    • 依治疗方式分類的历史市场规模分析，2019-2024 年
    • 依治疗方式分類的当前市场规模分析及预测（2025-2032 年）
      • 电脑断层扫描
      • MRI
      • X射线
  • 市场吸引力分析：模式
  • 全球诊断影像市场临床试验展望：治疗领域
    • 引言/主要发现
    • 按治疗领域分類的历史市场规模分析，2019-2024 年
    • 按治疗领域分類的当前市场规模分析及预测（2025-2032 年）
      • 肿瘤学
      • 神经病学
      • 心臟病学
      • 整形外科
      • 妇产科
  • 市场吸引力分析：治疗领域
  • 全球临床试验诊断成像市场展望：终端用户
    • 引言/主要发现
    • 按最终用户分類的历史市场规模和销售分析（2019-2024 年）
    • 按最终用户分類的当前市场规模和销售分析及预测（2025-2032 年）
      • 合约研究组织（CRO）
      • 製药和生物技术公司
      • 学术和政府研究机构

6. 全球临床试验诊断影像市场区域展望

  • 主要亮点
  • 2019-2024年各地区历史市场规模及销售分析
  • 目前市场规模及销售分析及预测（按地区划分，2025-2032年）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：区域

第七章：北美临床试验诊断影像市场展望：

第八章 欧洲临床试验诊断影像市场展望：

第九章 东亚临床试验影像诊断市场展望：

第十章 南亚和大洋洲临床试验影像诊断市场展望：

第十一章：拉丁美洲临床试验诊断影像市场展望：

第十二章：中东和非洲临床试验影像诊断市场展望：

第十三章 竞争格局

  • 2025年市占率分析
  • 市场结构
    • 市场竞争加剧地图
    • 竞争对手仪錶板
  • 公司简介（详情 - 概述、财务状况、策略、近期发展）
    • Ixico PLC
    • Navitas Life Sciences
    • Resonance Health
    • Radiant Sage LLC
    • Medpace
    • WCG Clinical
    • Icon PLC
    • Voiant
    • Clario
    • Parexel International Corporation
    • Anagram
    • Calyx
    • Invicro

第十四章附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP35178

Persistence Market Research has recently released a comprehensive report on the worldwide market for clinical trial imaging. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global clinical trial imaging market from 2025 to 2032.

Key Insights:

  • Clinical Trial Imaging Market Size (2025E): US$ 1.5 Bn
  • Projected Market Value (2032F): US$ 2.5 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 7.5%

Clinical Trial Imaging Market - Report Scope:

Clinical trial imaging refers to the use of medical imaging techniques such as MRI, CT scans, PET scans, and ultrasound in clinical trials to assess the efficacy and safety of new drugs, treatments, and medical devices. These imaging modalities help researchers in accurate disease diagnosis, treatment monitoring, and biomarker identification. The demand for clinical trial imaging is rising as pharmaceutical and biotechnology companies increasingly rely on imaging-based evidence to support regulatory approvals and accelerate drug development timelines.

Market Growth Drivers:

The global clinical trial imaging market is driven by several key factors, including the growing adoption of advanced imaging technologies in clinical research. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has fueled the demand for imaging-based biomarkers in drug trials. Moreover, the rising number of clinical trials globally, coupled with stringent regulatory requirements for imaging endpoints, is propelling market growth. Advancements in artificial intelligence (AI) and machine learning (ML) integration with imaging technologies are further enhancing image analysis accuracy, thus improving clinical trial outcomes.

Market Restraints:

Despite significant growth opportunities, the clinical trial imaging market faces challenges such as high costs associated with imaging modalities and infrastructure. The complexity of regulatory compliance in different regions also acts as a barrier to market expansion. Additionally, the shortage of skilled professionals for imaging data interpretation and analysis poses a challenge for efficient clinical trial execution. Delays in trial approvals and the variability in imaging protocols across different study sites further add to the operational complexities of this market.

Market Opportunities:

The clinical trial imaging market presents substantial growth opportunities driven by the increasing adoption of cloud-based imaging solutions and remote monitoring technologies. The development of AI-powered imaging software is expected to enhance real-time data processing and automate image analysis, reducing human errors. Additionally, strategic collaborations between pharmaceutical companies, contract research organizations (CROs), and imaging service providers are expected to streamline clinical trial imaging workflows. The expansion of clinical trials in emerging markets, particularly in Asia-Pacific, offers lucrative growth prospects for market players.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the clinical trial imaging market globally?
  • How does the integration of AI and machine learning enhance imaging capabilities in clinical trials?
  • Which therapeutic areas are leading in the adoption of clinical trial imaging solutions?
  • Who are the key players in the clinical trial imaging market, and what strategies are they employing to gain a competitive advantage?
  • What are the emerging trends and future growth prospects in the global clinical trial imaging market?

Competitive Intelligence and Business Strategy:

Leading players in the global clinical trial imaging market, including BioTelemetry, Parexel International Corporation, ICON plc, Medpace, and Biomedical Systems, focus on technological innovations, strategic partnerships, and service expansion to strengthen their market presence. Companies are investing in AI-driven imaging analysis platforms and cloud-based imaging solutions to improve clinical trial efficiency. Collaborations with pharmaceutical firms and CROs are facilitating the seamless integration of imaging endpoints in drug development studies. The increasing adoption of decentralized trials and remote imaging solutions is also shaping the future of clinical trial imaging, ensuring faster and more cost-effective trial execution.

Key Companies Profiled:

  • Ixico PLC
  • Navitas Life Sciences
  • Resonance Health
  • Radiant Sage LLC
  • Medpace
  • WCG Clinical
  • Icon PLC
  • Voiant
  • Clario
  • Parexel International Corporation
  • Anagram
  • Calyx
  • Invicro

Clinical Trial Imaging Market Segmentation

By Product & Services

  • Services
  • Software

By Modality

  • CT scan
  • MRI
  • X-Ray
  • Ultrasound

By Therapeutic Area

  • Oncology
  • Neurology
  • Cardiology
  • Orthopedics
  • Obstetrics & Gynecology

By End User

  • Contract Research Organizations (CROs)
  • Pharmaceutical & Biotechnology Companies
  • Academic and Government Research Institutes

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Clinical Trial Imaging Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product & Services Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2032

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product & Services Prices
  • 4.3. Pricing Analysis By Product & Services
  • 4.4. Regional Prices and Product & Services Preferences

5. Global Clinical Trial Imaging Market Outlook:

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Clinical Trial Imaging Market Outlook: Product & Services
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product & Services, 2019-2024
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
      • 5.3.3.1. Services
      • 5.3.3.2. Software
  • 5.4. Market Attractiveness Analysis: Product & Services
  • 5.5. Global Clinical Trial Imaging Market Outlook: Modality
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2024
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
      • 5.5.3.1. CT scan
      • 5.5.3.2. MRI
      • 5.5.3.3. X-Ray
  • 5.6. Market Attractiveness Analysis: Modality
  • 5.7. Global Clinical Trial Imaging Market Outlook: Therapeutic Area
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2019-2024
    • 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
      • 5.7.3.1. Oncology
      • 5.7.3.2. Neurology
      • 5.7.3.3. Cardiology
      • 5.7.3.4. Orthopedics
      • 5.7.3.5. Obstetrics & Gynecology
  • 5.8. Market Attractiveness Analysis: Therapeutic Area
  • 5.9. Global Clinical Trial Imaging Market Outlook: End User
    • 5.9.1. Introduction / Key Findings
    • 5.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By End User, 2019-2024
    • 5.9.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
      • 5.9.3.1. Contract Research Organizations (CROs)
      • 5.9.3.2. Pharmaceutical & Biotechnology Companies
      • 5.9.3.3. Academic and Government Research Institutes

6. Global Clinical Trial Imaging Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Clinical Trial Imaging Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product & Services
    • 7.2.3. By Modality
    • 7.2.4. By Therapeutic Area
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 7.4.1. Services
    • 7.4.2. Software
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 7.5.1. CT scan
    • 7.5.2. MRI
    • 7.5.3. X-Ray
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 7.6.1. Oncology
    • 7.6.2. Neurology
    • 7.6.3. Cardiology
    • 7.6.4. Orthopedics
    • 7.6.5. Obstetrics & Gynecology
  • 7.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 7.7.1. Contract Research Organizations (CROs)
    • 7.7.2. Pharmaceutical & Biotechnology Companies
    • 7.7.3. Academic and Government Research Institutes
  • 7.8. Market Attractiveness Analysis

8. Europe Clinical Trial Imaging Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product & Services
    • 8.2.3. By Modality
    • 8.2.4. By Therapeutic Area
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 8.4.1. Services
    • 8.4.2. Software
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 8.5.1. CT scan
    • 8.5.2. MRI
    • 8.5.3. X-Ray
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 8.6.1. Oncology
    • 8.6.2. Neurology
    • 8.6.3. Cardiology
    • 8.6.4. Orthopedics
    • 8.6.5. Obstetrics & Gynecology
  • 8.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 8.7.1. Contract Research Organizations (CROs)
    • 8.7.2. Pharmaceutical & Biotechnology Companies
    • 8.7.3. Academic and Government Research Institutes
  • 8.8. Market Attractiveness Analysis

9. East Asia Clinical Trial Imaging Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product & Services
    • 9.2.3. By Modality
    • 9.2.4. By Therapeutic Area
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 9.4.1. Services
    • 9.4.2. Software
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 9.5.1. CT scan
    • 9.5.2. MRI
    • 9.5.3. X-Ray
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 9.6.1. Oncology
    • 9.6.2. Neurology
    • 9.6.3. Cardiology
    • 9.6.4. Orthopedics
    • 9.6.5. Obstetrics & Gynecology
  • 9.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 9.7.1. Contract Research Organizations (CROs)
    • 9.7.2. Pharmaceutical & Biotechnology Companies
    • 9.7.3. Academic and Government Research Institutes
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Clinical Trial Imaging Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product & Services
    • 10.2.3. By Modality
    • 10.2.4. By Therapeutic Area
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 10.4.1. Services
    • 10.4.2. Software
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 10.5.1. CT scan
    • 10.5.2. MRI
    • 10.5.3. X-Ray
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 10.6.1. Oncology
    • 10.6.2. Neurology
    • 10.6.3. Cardiology
    • 10.6.4. Orthopedics
    • 10.6.5. Obstetrics & Gynecology
  • 10.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 10.7.1. Contract Research Organizations (CROs)
    • 10.7.2. Pharmaceutical & Biotechnology Companies
    • 10.7.3. Academic and Government Research Institutes
  • 10.8. Market Attractiveness Analysis

11. Latin America Clinical Trial Imaging Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product & Services
    • 11.2.3. By Modality
    • 11.2.4. By Therapeutic Area
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 11.4.1. Services
    • 11.4.2. Software
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 11.5.1. CT scan
    • 11.5.2. MRI
    • 11.5.3. X-Ray
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 11.6.1. Oncology
    • 11.6.2. Neurology
    • 11.6.3. Cardiology
    • 11.6.4. Orthopedics
    • 11.6.5. Obstetrics & Gynecology
  • 11.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 11.7.1. Contract Research Organizations (CROs)
    • 11.7.2. Pharmaceutical & Biotechnology Companies
    • 11.7.3. Academic and Government Research Institutes
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Clinical Trial Imaging Market Outlook:

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product & Services
    • 12.2.3. By Modality
    • 12.2.4. By Therapeutic Area
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 12.4.1. Services
    • 12.4.2. Software
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 12.5.1. CT scan
    • 12.5.2. MRI
    • 12.5.3. X-Ray
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 12.6.1. Oncology
    • 12.6.2. Neurology
    • 12.6.3. Cardiology
    • 12.6.4. Orthopedics
    • 12.6.5. Obstetrics & Gynecology
  • 12.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 12.7.1. Contract Research Organizations (CROs)
    • 12.7.2. Pharmaceutical & Biotechnology Companies
    • 12.7.3. Academic and Government Research Institutes
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Ixico PLC
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product & Services Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Navitas Life Sciences
    • 13.3.3. Resonance Health
    • 13.3.4. Radiant Sage LLC
    • 13.3.5. Medpace
    • 13.3.6. WCG Clinical
    • 13.3.7. Icon PLC
    • 13.3.8. Voiant
    • 13.3.9. Clario
    • 13.3.10. Parexel International Corporation
    • 13.3.11. Anagram
    • 13.3.12. Calyx
    • 13.3.13. Invicro

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations